Abstract
Several studies have shown a correlation between obstructive sleep apnea (OSA) and obesity, as well as obesity and diabetes mellitus. This is probably related to the fact that patients with OSA are likely to have a high prevalence of the risk factors that comprise metabolic syndrome. It has been shown that sleep deprivation when induced experimentally can cause glucose intolerance and many studies have established the association between sleep apnea and type two diabetes mellitus. There is also a proven association between snoring and sleep apnea as well as snoring and metabolic syndrome. In the current article we review the patho-physiology of hyperglycemia, insulin resistance due to sleep apnea, and treatment of OSA with continuous positive airway pressure therapy. Continuous positive airway pressure (CPAP) does, in fact, lead to improvement in insulin resistance and lowered hemoglobin A1C levels. The question that remains to be answered is whether the association between sleep apnea and the components of metabolic syndrome is one of co-existence or causality, but it can no longer be denied that there is a strong relationship which should lead to investigation of one if the other is found.
Keywords: Sleep apnea, sleep disordered breathing, diabetes mellitus, hyperglycemia, apnea
Current Respiratory Medicine Reviews
Title: Association of Sleep Apnea Syndrome and Diabetes Mellitus
Volume: 3 Issue: 4
Author(s): Salim Surani and Joseph Varon
Affiliation:
Keywords: Sleep apnea, sleep disordered breathing, diabetes mellitus, hyperglycemia, apnea
Abstract: Several studies have shown a correlation between obstructive sleep apnea (OSA) and obesity, as well as obesity and diabetes mellitus. This is probably related to the fact that patients with OSA are likely to have a high prevalence of the risk factors that comprise metabolic syndrome. It has been shown that sleep deprivation when induced experimentally can cause glucose intolerance and many studies have established the association between sleep apnea and type two diabetes mellitus. There is also a proven association between snoring and sleep apnea as well as snoring and metabolic syndrome. In the current article we review the patho-physiology of hyperglycemia, insulin resistance due to sleep apnea, and treatment of OSA with continuous positive airway pressure therapy. Continuous positive airway pressure (CPAP) does, in fact, lead to improvement in insulin resistance and lowered hemoglobin A1C levels. The question that remains to be answered is whether the association between sleep apnea and the components of metabolic syndrome is one of co-existence or causality, but it can no longer be denied that there is a strong relationship which should lead to investigation of one if the other is found.
Export Options
About this article
Cite this article as:
Surani Salim and Varon Joseph, Association of Sleep Apnea Syndrome and Diabetes Mellitus, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359850
DOI https://dx.doi.org/10.2174/157339807782359850 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
Current Pharmaceutical Biotechnology Beneficial Effects of Melatonin and Atorvastatin on Retinopathy in Streptozocin-induced Diabetic Rats
Current Drug Therapy Stem Cells: In Sickness and in Health
Current Stem Cell Research & Therapy Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part -II
Current Topics in Medicinal Chemistry Protein Degradation by the Ubiquitin-Proteasome Pathway and Organ Fibrosis
Current Medicinal Chemistry Amyloid Forming Proteases: Therapeutic Targets for Alzheimers Disease
Current Pharmaceutical Design Drug Development from Natural Resource: A Systematic Approach
Mini-Reviews in Medicinal Chemistry New Hybrid Scaffolds based on Hydrazinyl Thiazole Substituted Coumarin; As Novel Leads of Dual Potential; In Vitro α-Amylase Inhibitory and Antioxidant (DPPH and ABTS Radical Scavenging) Activities
Medicinal Chemistry New Aspects of Statin Safety
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants
Current Pharmaceutical Design Roles of p38-MAPK in Insulin Resistant Heart: Evidence from Bench to Future Bedside Application
Current Pharmaceutical Design Structure Guided Molecular Docking Assisted Alignment Dependent 3DQSAR Study on Steroidal Aromatase Inhibitors (SAIs) as Anti-breast Cancer Agents
Letters in Drug Design & Discovery Pathogenesis and Management of Hypertension after Kidney Transplantation
Current Hypertension Reviews Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis
Current Diabetes Reviews Nutrapharmacology of Tocotrienols for Metabolic Syndrome
Current Pharmaceutical Design Effects of Mesenchymal Stromal Cells on Diabetic Cardiomyopathy
Current Pharmaceutical Design Progress in the Diagnosis and Treatment of Pulmonary Aspergillosis
Current Respiratory Medicine Reviews Metabolic and Appetite Effects of Fructose and Glucose in Subjects with Type 1 Diabetes: A Randomized Crossover Clinical Trial
Current Diabetes Reviews Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Editorial: (Thematic Issue: Vascular Pathophysiology of Alzheimer`s Disease)
Current Alzheimer Research